AcetaZOLAMIDE Tablets — Class III drug recall D-0659-2024
Ongoing recall by Rubicon Research Private Limited, reported 2024-09-25, distributed nationwide. Discoloration
| Recall number | D-0659-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Rubicon Research Private Limited, Ambarnath, India |
| Recall initiated | 2024-08-24 |
| Classified | 2024-09-13 |
| Reported by FDA | 2024-09-25 |
| Distributed | Nationwide (US) |
| Quantity | 3,984 bottles |
| NDC | 72888-0047, 72888-0047-01, 72888-0048, 72888-0048-01 |
| Lot numbers | 30575HF1 |
| Expiration dates | 2026-11-20 |
Product
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
Reason for recall
Discoloration
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0659-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.